Project Management in Drug Development: Phase I and Phase II
Agenda: Day Two
VI. Phase I: Project Implementation, Monitoring and Control
-
Develop decision-making criteria
-
Outline the decision-making process
-
Conduct project review meetings
-
Inform senior management and secure endorsement
-
Make decisions based on risk management
Exercise: Compile a Master List of Critical Decision-Making Criteria
VII. Transition from Phase I to Phase II
-
Define "handoff"
-
Execute the successful "handoff"
-
Determine when to begin the transition
-
Define the role of the commercial group
VIII. Phase II: Project Team and Emerging Target Product Profile
-
Examine possible changes in the functional composition of the team
-
Form the Development Team
-
identify sub-teams (e.g., strategy sub-team)
-
develop internal and external stakeholder communication plan
-
supply chain management
-
technology transfer
-
-
Review the ongoing iterative process of assessing the Target Product Profile against current data and information
Exercise:Review the TPP from Day One and Revise if Necessary
IX. Phase II: Setting Project Objectives
-
Define objectives appropriate to Phase II development
-
publications strategy
-
patent strategy
-
additional work on metabolism
-
special populations
-
-
Apply risk management strategies
Exercise: Risk Planning
X. Phase II: Project Timeline
-
Plan for the End of Phase II meeting with regulators
-
Develop Proof of Concept
XI. Phase II: Project Monitoring and Control
-
Evaluate ongoing activities through Phase II
-
Prepare for transition to Phase III
-
Determine the brand team and key objectives related to brand management
Exercise:Review Goals and Objectives from the Beginning of Day One and Ensure All Have Been Met
Booking Options
This course is available exclusively as an onsite training solution. To discuss a solution that fits your organization's needs, objectives, schedule and budget, contact a PTi Client Solutions Manager at 800-303-8194 or OnSiteSolutions@pti-international.com.